The RISE Consortium study did not ane differences in measures of Children and diabetes management or ddiabetes function Chidren between Cigarette smoke and insulin, Chidlren there was more weight gain with insulin The epidemiology, pathophysiology, diabeted considerations, and response to therapy in pediatric diabetes are often different from adult diabetes. Am Psychol ;— Eating disorders should be suspected in those adolescent and young adult females who are unable to achieve and maintain metabolic targets, especially when insulin omission is suspected. Diabetic neuropathy: a position statement by the American Diabetes Association. Teenage pregnancy in type 1 diabetes mellitus. toolbar search Search Dropdown Menu.

Children and diabetes management -

References Glasgow AM,Weissberg-Benchell J, Tynan WD, et al. Pediatrics ;— von Sengbusch S, Muller-Godeffroy E, Hager S, et al. Mobile diabetes education and care: Intervention for children and young people with type 1 diabetes in rural areas of northern Germany.

Diabet Med ;—7. Pillay J, Armstrong MJ, Butalia S, et al. Behavioral programs for type 1 diabetes mellitus: A systematic review and meta-analysis. Ann Intern Med ;— Price KJ, Knowles JA, Fox M, et al. Effectiveness of the Kids in Control of Food KICk-OFF structured education course for 11—16 year olds with Type 1 diabetes.

Diabet Med ;— Basarir H, Brennan A, Jacques R, et al. Cost-effectiveness of structured education in children with type-1 diabetes mellitus. Int J Technol Assess Health Care ;— Clar C,Waugh N, Thomas S. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus.

Cochrane Database Syst Rev ; 2 :CD Tonyushkina KN, Visintainer PF, Jasinski CF, et al. Site of initial diabetes education does not affect metabolic outcomes in children with T1DM.

Pediatr Diabetes ;— The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Eng J Med ;— Diabetes Control and Complications Trial Research Group.

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes control and complications trial.

J Pediatr ;— Swift PG, Skinner TC, de Beaufort CE, et al. Target setting in intensive insulin management is associated with metabolic control: The Hvidoere childhood diabetes study group centre differences study Pediatr Diabetes ;—8.

Maahs DM, Hermann JM, DuBose SN, et al. Diabetologia ;— Aye T, Barnea-Goraly N, Ambler C, et al. White matter structural differences in young children with type 1 diabetes: A diffusion tensor imaging study. Diabetes Care ;— Barnea-Goraly N, Raman M, Mazaika P, et al. Alterations in white matter structure in young children with type 1 diabetes.

Blasetti A, Chiuri RM, Tocco AM, et al. The effect of recurrent severe hypoglycemia on cognitive performance in children with type 1 diabetes: A metaanalysis. J Child Neurol ;— Hershey T, Perantie DC, Warren SL, et al. Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes.

Diabetes Care ;—7. Gaudieri PA, Chen R, Greer TF, et al. Cognitive function in children with type 1 diabetes: A meta-analysis. Robertson KJ, Schoenle E, Gucev Z, et al. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

Chase HP, Arslanian S, White NH, et al. Insulin glargine versus intermediateacting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus. Pihoker C, Badaru A, Anderson A, et al. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: The SEARCH for Diabetes in Youth study.

Phillip M, Battelino T, Rodriguez H, et al. Use of insulin pump therapy in the pediatric age-group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes.

Levy-Shraga Y, Lerner-Geva L, Modan-Moses D, et al. Benefits of Continuous Subcutaneous Insulin Infusion CSII therapy in preschool children. Exp Clin Endocrinol Diabetes ;—9. McMahon SK, Airey FL, Marangou DA, et al.

Insulin pump therapy in children and adolescents: Improvements in key parameters of diabetes management including quality of life.

Diabet Med ;—6. Misso ML, Egberts KJ, Page M, et al. Continuous Subcutaneous Insulin Infusion CSII versus multiple insulin injections for type 1 diabetes mellitus.

Cochrane Database Syst Rev ; 1 :CD Weinzimer SA, Sikes KA, Steffen AT, et al. Insulin pump treatment of childhood type 1 diabetes. Pediatr Clin North Am ;— Johnson SR, Cooper MN, Jones TW, et al.

Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large populationbased case-control study. Overgaard Ingeholm I, Svensson J, Olsen B, et al. Characterization of metabolic responders on CSII treatment amongst children and adolescents in Denmark from to Diabetes Res Clin Pract ;— Bergenstal RM, Tamborlane WV, Ahmann A, et al.

Effectiveness of sensoraugmented insulin-pump therapy in type 1 diabetes. N Engl J Med ;— Alemzadeh R, Berhe T, Wyatt DT. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschoolaged children with type 1 diabetes mellitus.

Pediatrics ;—4. Murphy NP, Keane SM, Ong KK, et al. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens. Hassan K, Rodriguez LM, Johnson SE, et al.

A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn NPH therapy in newly diagnosed type 1 diabetes.

Pediatrics ;e— Thalange N, Bereket A, Larsen J, et al. Insulin analogues in children with type 1 diabetes: A week randomized clinical trial. Thalange N, Deeb L, Iotova V, et al. Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes.

de Beaufort CE, Swift PG, Skinner CT, et al. Continuing stability of center differences in pediatric diabetes care: Do advances in diabetes treatment improve outcome?

The Hvidoere Study Group on Childhood Diabetes. Rosenbauer J, Dost A, Karges B, et al. Improved metabolic control in children and adolescents with type 1 diabetes: A trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care ;—6. Formosa N. Blood glucose monitoring in children and adolescents with type 1 diabetes mellitus.

MMJ ;—5. Nordly S, Mortensen HB, Andreasen AH, et al. Factors associated with glycaemic outcome of childhood diabetes care in Denmark. Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants.

Mauras N, Fox L, Englert K, et al. Continuous glucose monitoring in type 1 diabetes. Endocrine ;— Rachmiel M, Landau Z, Boaz M, et al. The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in reallife settings: The AWeSoMe Study Group experience.

Acta Diabetol ;—9. Hommel E, Olsen B, Battelino T, et al. Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study.

Acta Diabetol ;— The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Matsuda E, Brennan P. The effectiveness of continuous glucose monitoring for type 1 diabetic adolescents using continuous subcutaneous insulin infusion pumps: A systematic review. JBI Database System Rev Implement Rep ;— Buckingham BA, Raghinaru D, Cameron F, et al. Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis.

Maahs DM, Calhoun P, Buckingham BA, et al. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Thabit H, Tauschmann M, Allen JM, et al.

Home use of an artificial beta cell in type 1 diabetes. New Engl J Med ;— Health Canada. Ottawa, ON, Health Products and Food Branch, Office of Nutrition Policy and Promotion: Health Canada; Report No.

Mehta SN, Volkening LK, Quinn N, et al. Intensively managed young children with type 1 diabetes consume high-fat, low-fiber diets similar to agematched controls. Nutr Res ;— Markowitz JT, Butler DA, Volkening LK, et al.

Brief screening tool for disordered eating in diabetes: Internal consistency and external validity in a contemporary sample of pediatric patients with type 1 diabetes.

Naguib JM, Kulinskaya E, Lomax CL, et al. Neuro-cognitive performance in children with type 1 diabetes—a meta-analysis.

J Pediatr Psychol ;— Garg S, Moser E, Dain MP, et al. Clinical experience with insulin glargine in type 1 diabetes. Diabetes Technol Ther ;— Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring JDRF-CGM trial.

Hartley M, Thomsett MJ, Cotterill AM. Mini-dose glucagon rescue for mild hypoglycaemia in children with type 1 diabetes: The Brisbane experience.

J Paediatr Child Health ;— Haymond MW, Schreiner B. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes. Diabetes Care ;—5. Kongkaew C, Jampachaisri K, Chaturongkul CA, et al. Depression and adherence to treatment in diabetic children and adolescents: A systematic review and meta-analysis of observational studies.

Eur J Pediatr ;— Young V, Eiser C, Johnson B, et al. Eating problems in adolescents with type 1 diabetes: A systematic review with meta-analysis. Demographic and personal factors associated with metabolic control and self-care in youth with type 1 diabetes: A systematic review. Diabetes Metab Res Rev ;— Drotar D, Ittenbach R, Rohan JM, et al.

Diabetes management and glycemic control in youth with type 1 diabetes: Test of a predictive model. J Behav Med ;— Schwartz DD, Axelrad ME, Anderson BJ. A psychosocial risk index for poor glycemic control in children and adolescents with type 1 diabetes.

Pediatr Diabetes ;—7. Winkley K, Ismail K, Landau S, et al. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: Systematic review and meta-analysis of randomised controlled trials.

BMJ ; Hood KK, Rohan JM, Peterson CM, et al. Interventions with adherencepromoting components in pediatric type 1 diabetes: Meta-analysis of their impact on glycemic control. Armour TA, Norris SL, Jack L Jr, et al.

The effectiveness of family interventions in people with diabetes mellitus: A systematic review. Quirk H, Blake H, Tennyson R, et al.

Physical activity interventions in children and young people with Type 1 diabetes mellitus: A systematic review with meta-analysis. MacMillan F, Kirk A, Mutrie N, et al. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: Study characteristics, intervention design, and efficacy.

Lévy-Marchal C, Patterson CC, Green A, et al. Geographical variation of presentation at diagnosis of type I diabetes in children: The EURODIAB study. Diabetologia ;B75— Klingensmith GJ, Tamborlane WV, Wood J, et al.

Diabetic ketoacidosis at diabetes onset: Still an all too common threat in youth. J Pediatr ;—4, e1. Patterson CC, Dahlquist G, Harjutsalo V, et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since Cameron FJ, Scratch SE, Nadebaum C, et al.

Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children.

Glaser NS,Wootton-Gorges SL, Buonocore MH, et al. Subclinical cerebral edema in children with diabetic ketoacidosis randomized to 2 different rehydration protocols.

Pediatrics ;e73— Vanelli M, Chiari G, Ghizzoni L, et al. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices.

Diabetes Care ;—9. King BR, Howard NJ, Verge CF, et al. A diabetes awareness campaign prevents diabetic ketoacidosis in children at their initial presentation with type 1 diabetes. Brink S, Joel D, Laffel L, et al. ISPAD clinical practice consensus guidelines Sick day management in children and adolescents with diabetes.

Keenan HT, Foster CM, Bratton SL. Social factors associated with prolonged hospitalization among diabetic children. Hanas R, Lindgren F, Lindblad B. A 2-yr national population study of pediatric ketoacidosis in Sweden: Predisposing conditions and insulin pump use.

Karges B, Kapellen T, Neu A, et al. Long-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes: A prospective study of 10, patients from institutions. Diabetes Care ;—3.

Maahs DM, Hermann JM, Holman N, et al. Rates of diabetic ketoacidosis: International comparison with 49, pediatric patients with type 1 diabetes rrom England, wales, the U. Drozda DJ, Dawson VA, Long DJ, et al.

Assessment of the effect of a comprehensive diabetes management program on hospital admission rates of children with diabetes mellitus. Diabetes Educ ;— Ellis D, Naar-King S, Templin T, et al. Multisystemic therapy for adolescents with poorly controlled type 1 diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months.

Service and education for the insulindependent child. Diabetes Care ;—8. Chiari G, Ghidini B, Vanelli M. Effectiveness of a toll-free telephone hotline for children and adolescents with type 1 diabetes.

a 5-year study. Acta Biomed ;—8. Wagner DV, Stoeckel M, E Tudor M, et al. Treating the most vulnerable and costly in diabetes.

Curr Diab Rep ; Edge JA, Hawkins MM, Winter DL, et al. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child ;— Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Glaser N, Barnett P, McCaslin I, et al.

Risk factors for cerebral edema in children with diabetic ketoacidosis. The pediatric emergency medicine collaborative research committee of the American Academy of Pediatrics. N Engl J Med ;—9.

Harris GD, Fiordalisi I, Harris WL, et al. Minimizing the risk of brain herniation during treatment of diabetic ketoacidemia: A retrospective and prospective study. Harris GD, Fiordalisi I. Physiologic management of diabetic ketoacidemia.

A 5-year prospective pediatric experience in episodes. Arch Pediatr Adolesc Med ;— Hale PM, Rezvani I, Braunstein AW, et al. Factors predicting cerebral edema in young children with diabetic ketoacidosis and new onset type I diabetes.

Acta Paediatr ;— Edge JA, Jakes RW, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia ;—9.

Fort P,Waters SM, Lifshitz F. Low-dose insulin infusion in the treatment of diabetic ketoacidosis: Bolus versus no bolus. Lindsay R, Bolte RG. The use of an insulin bolus in low-dose insulin infusion for pediatric diabetic ketoacidosis.

Pediatr Emerg Care ;—9. Hoorn EJ, Carlotti AP, Costa LA, et al. Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis.

Nallasamy K, Jayashree M, Singhi S, et al. Low-dose vs standard-dose insulin in pediatric diabetic ketoacidosis: A randomized clinical trial. JAMA Pediatr ;— Decourcey DD, Steil GM,Wypij D, et al. Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: An year retrospective analysis of mortality.

Pediatr Crit Care Med ;— Wolfsdorf JI, Allgrove J, Craig ME, et al. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. National Advisory Committee on Immunization NACI. NACI recommendations, statements and updates. Ottawa: Public Health Agency of Canada.

Moore DL; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Paediatr Child Health ;— Davies P, Nwokoro C, Leigh M. Vaccinations against influenza and pneumococcus in children with diabetes: Telephone questionnaire survey.

Irwin DE, Weatherby LB, Huang W-Y, et al. BMC Health Serv Res ; Scott LJ, Warram JH, Hanna LS, et al. A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes.

Diabetes ;—9. Hofer SE, Rosenbauer J, Grulich-Henn J, et al. Smoking and metabolic control in adolescents with type 1 diabetes. J Pediatr ;—3, e1. Harvey J, Chadi N, Canadian Paediatric Society Adolescent Health Committee. Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37, patients between and Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study.

Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes. Occurrence of severe hypoglycaemic events among US youth and young adults with type 1 or type 2 diabetes.

Incidence trends and predictors of hospitalization for hypoglycemia in 17, adult patients with type 1 diabetes: a Danish Register linkage cohort study. Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study DPV Initiative of the German Working Group for Pediatric Diabetology; German BMBF Competence Network for Diabetes Mellitus.

Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.

Autoimmune diseases in children and adults with type 1 diabetes from the T1D Exchange Clinic Registry. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis.

Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with type 1 diabetes. Hyperthyroidism in children and adolescents with type 1 diabetes from Germany and Austria.

Thyroid and islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with type 1 diabetes mellitus.

Australasian Diabetes Data Network ADDN ; T1D Exchange Clinic Network T1DX ; National Paediatric Diabetes Audit NPDA and the Royal College of Paediatrics and Child Health; Prospective Diabetes Follow-up Registry DPV initiative.

Prevalence of celiac disease in 52, youth with type 1 diabetes: international comparison across three continents. Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology.

Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: analysis of the Type 1 Diabetes Exchange Clinic Registry.

Bone health in children with celiac disease assessed by dual x-ray absorptiometry: effect of gluten-free diet and predictive value of serum biochemical indices.

Microvascular complications in childhood-onset type 1 diabetes and celiac disease: a multicenter longitudinal analysis of 56, patients from the German-Austrian DPV database. A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease.

Evidence supporting serology-based pathway for diagnosing celiac disease in asymptomatic children from high-risk groups.

Clinical and metabolic effects of gluten free diet in children with type 1 diabetes and coeliac disease. ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease. de Ferranti. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

Prevalence of cardiovascular disease risk factors in U. children and adolescents with diabetes: the SEARCH for Diabetes in Youth study. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study.

Spectrum and prevalence of atherogenic risk factors in 27, children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system DPV. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus.

Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes. Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex: the SEARCH for Diabetes in Youth Study.

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report.

Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes. American Heart Association Expert Panel on Population and Prevention Science; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity and Metabolism; American Heart Association Council on High Blood Pressure Research; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on the Kidney in Heart Disease; Interdisciplinary Working Group on Quality of Care and Outcomes Research.

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.

Lipid profile and nutritional intake in children and adolescents with Type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet. Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial.

American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee; American Heart Association Council of Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular Nursing.

Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.

Serum cholesterol ester fatty acids in 7- and month-old children in a prospective randomized trial of a low-saturated fat, low-cholesterol diet: the STRIP baby project: Special Turku coronary Risk factor Intervention Project for children.

Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.

Educational disparities in rates of smoking among diabetic adults: the translating research into action for diabetes study. Prevalence of tobacco use and association between cardiometabolic risk factors and cigarette smoking in youth with type 1 or type 2 diabetes mellitus.

A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Electronic cigarette use and progression from experimentation to established smoking.

Adolescent e-cigarette, hookah, and conventional cigarette use and subsequent marijuana use. Centers for Disease Control and Prevention. Outbreak of lung injury associated with e-cigarette use, or vaping. Accessed 27 September Factors associated with microalbuminuria in 7, children and adolescents with type 1 diabetes in the T1D Exchange clinic registry.

Estimating glomerular filtration rate from serum creatinine and cystatin C. Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from to Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.

Treatable diabetic retinopathy is extremely rare among pediatric T1D Exchange clinic registry participants. Screening eye exams in youth with type 1 diabetes under 18 years of age: once may be enough? Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for Diabetes in Youth Study.

Diabetic neuropathy: a position statement by the American Diabetes Association. Projections of type 1 and type 2 diabetes burden in the U.

Prevalence of diabetes in U. youth in the SEARCH for diabetes in youth study. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.

Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study.

Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Early adversity, psychopathology, and latent class profiles of global physical health from preschool through early adolescence.

Prevalence of type 1 and type 2 diabetes among children and adolescents from to Diabetes screening with hemoglobin A 1c versus fasting plasma glucose in a multiethnic middle-school cohort. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study.

The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes. Hemoglobin A1c measurement for the diagnosis of type 2 diabetes in children. Using hemoglobin A1c for prediabetes and diabetes diagnosis in adolescents: can adult recommendations be upheld for pediatric use?

Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for Diabetes in Youth Study.

Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under Excess BMI in childhood: a modifiable risk factor for type 1 diabetes development? Reference removed during proofreading. Diabetic ketoacidosis among obese African-American adolescents with NIDDM.

TODAY Study Group. Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience. Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial.

Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial.

Development of a diabetes education program for youth with type 2 diabetes. American Diabetes Association. Be Healthy Today; Be Healthy For Life. Meeting quality standards for self-management education in pediatric type 2 diabetes.

Management of newly diagnosed type 2 diabetes mellitus T2DM in children and adolescents. A clinical trial to maintain glycemic control in youth with type 2 diabetes. RISE Consortium. Impact of insulin and metformin versus metformin alone on β-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes.

Food and Drug Administration. FDA approves new treatment for pediatric patients with type 2 diabetes. Accessed 20 September Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.

Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. A multidisciplinary approach to the adolescent bariatric surgical patient. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group.

Teen-Longitudinal Assessment of Bariatric Surgery: methodological features of the first prospective multicenter study of adolescent bariatric surgery. Cardiovascular risk factors in severely obese adolescents: the Teen Longitudinal Assessment of Bariatric Surgery Teen-LABS study.

Laparoscopic gastric plication in morbidly obese adolescents: a prospective study. Laparoscopic Roux-en-Y gastric bypass in adolescents with morbid obesity--surgical aspects and clinical outcome. Insulin sensitivity and β-cell function improve after gastric bypass in severely obese adolescents.

Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society clinical practice guideline. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes.

Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort. ISPAD Clinical Practice Consensus Guidelines Type 2 diabetes in the child and adolescent.

Complication characteristics between young-onset type 2 versus type 1 diabetes in a UK population. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study.

Levitt Katz. Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children. Eating disorders in adolescents with type 1 diabetes: challenges in diagnosis and treatment.

Binge eating, mood, and quality of life in youth with type 2 diabetes: baseline data from the today study. The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study.

Pregnancy outcomes in youth with type 2 diabetes: the TODAY study experience. Emerging adulthood: a theory of development from the late teens through the twenties. Transitioning from pediatric to adult care: a new approach to the post-adolescent young person with type 1 diabetes. Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society formerly Lawson Wilkins Pediatric Endocrine Society.

Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study. Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes.

An evaluation of recurrent diabetic ketoacidosis, fragmentation of care, and mortality across Chicago, Illinois. Transition from pediatric to adult care for youth diagnosed with type 1 diabetes in adolescence. Transfer from pediatric to adult health care: effects on diabetes outcomes.

Health care transition preparation and experiences in a U. national sample of young adults with type 1 diabetes. The Endocrine Society. Managing the transition of care for patients with type 1 diabetes. CoYoT1 Clinic: home telemedicine increases young adult engagement in diabetes care.

Closing the gap: results of the multicenter canadian randomized controlled trial of structured transition in young adults with type 1 diabetes.

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services TrACeD : a randomised, open-label, controlled trial.

Components of interventions that improve transitions to adult care for adolescents with type 1 diabetes. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

View Metrics. Email alerts Article Activity Alert. Online Ahead of Print Alert. Latest Issue Alert. Online ISSN Print ISSN Books ShopDiabetes. org ADA Professional Books Clinical Compendia Clinical Compendia Home News Latest News DiabetesPro SmartBrief. Resources ADA Professional Membership ADA Member Directory Diabetes.

X Twitter Facebook LinkedIn. This Feature Is Available To Subscribers Only Sign In or Create an Account. Close Modal. This site uses cookies. Although scientific evidence is limited, it is clear that comprehensive and coordinated planning that begins in early adolescence is necessary to facilitate a seamless transition from pediatric to adult health care , , , New technologies and other interventions are being tried to support the transition to adult care in young adulthood — The Endocrine Society, in collaboration with the ADA and other organizations, has developed transition tools for clinicians and youth and families Suggested citation: American Diabetes Association Professional Practice Committee.

Children and adolescents: Standards of Medical Care in Diabetes— Diabetes Care ;45 Suppl. Sign In or Create an Account. Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Diabetes Care. Advanced Search.

User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Previous Article Next Article. Type 1 Diabetes. Type 2 Diabetes. Transition from Pediatric to Adult Care.

Article Navigation. Standards of Care December 16 Children and Adolescents: Standards of Medical Care in Diabetes— American Diabetes Association Professional Practice Committee American Diabetes Association Professional Practice Committee. This Site. Google Scholar.

Get Permissions. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest. Thyroid disease. Celiac disease. Corresponding recommendations ARB, angiotensin receptor blocker; NA, not applicable; tTG, tissue transglutaminase.

View Large. Nonalcoholic fatty liver disease. Obstructive sleep apnea. Polycystic ovarian syndrome for adolescent females. Corresponding recom mendations ARB, angiotensin receptor blocker; NA, not applicable. Figure View large Download slide. Accessed 20 October Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association.

Search ADS. Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank.

Alterations in white matter structure in young children with type 1 diabetes. Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children.

Developmental changes in the roles of patients and families in type 1 diabetes management. Are children with type 1 diabetes safe at school? Examining parent perceptions. Diabetes care in the school setting: a position statement of the American Diabetes Association. Care of young children with diabetes in the child care setting: a position statement of the American Diabetes Association.

Benefits of physical activity in children and adolescents with type 1 diabetes: a systematic review. Department of Health and Human Services. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes.

Glucose management for exercise using continuous glucose monitoring CGM and intermittently scanned CGM isCGM systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes EASD and of the International Society for Pediatric and Adolescent Diabetes ISPAD endorsed by JDRF and supported by the American Diabetes Association ADA.

Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study.

Prolonged exercise in type 1 diabetes: performance of a customizable algorithm to estimate the carbohydrate supplements to minimize glycemic imbalances. Evaluation of glucose control when a new strategy of increased carbohydrate supply is implemented during prolonged physical exercise in type 1 diabetes.

Acute effects of carbohydrate supplementation on intermittent sports performance. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Type 1 Diabetes Exchange Clinic Network and Diabetes Prospective Follow-up Registry.

Obesity in youth with type 1 diabetes in Germany, Austria, and the United States. Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index.

Psychosocial burden and glycemic control during the first 6 years of diabetes: results from the SEARCH for Diabetes in Youth study.

Diabetes distress among adolescents with type 1 diabetes: a systematic review. Factors associated with diabetes-specific health-related quality of life in youth with type 1 diabetes: the global TEENs study.

Screening and support for emotional burdens of youth with type 1 diabetes: strategies for diabetes care providers. Psychometric properties of the problem areas in diabetes: teen and parent of teen versions. Demographic and clinical correlates of diabetes-related quality of life among youth with type 1 diabetes.

Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Brief screening tool for disordered eating in diabetes: internal consistency and external validity in a contemporary sample of pediatric patients with type 1 diabetes.

Family-based psychoeducation and Care Ambassador intervention to improve glycemic control in youth with type 1 diabetes: a randomized trial. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetes.

Implications of psychosocial factors for diabetes outcomes among children with type 1 diabetes: a review. Factors associated with academic achievement in children with type 1 diabetes.

The legal authority of mature minors to consent to general medical treatment. Long-term effects of the booster-enhanced READY-Girls preconception counseling program on intentions and behaviors for family planning in teens with diabetes.

Disturbed eating behavior and omission of insulin in adolescents receiving intensified insulin treatment: a nationwide population-based study. Disturbed eating behaviors and eating disorders in type 1 diabetes: clinical significance and treatment recommendations.

Reliability and validity of the diabetes eating problem survey in Turkish children and adolescents with type 1 diabetes mellitus. Psychometric properties of the German version of the Diabetes Eating Problem Survey-Revised: additional benefit of disease-specific screening in adolescents with type 1 diabetes.

Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria.

Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial DCCT.

Glycemic control and complications in patients with type 1 diabetes — a registry-based longitudinal study of adolescents and young adults. HbA 1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications EDIC study. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.

Longitudinal assessment of hippocampus structure in children with type 1 diabetes. Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Brain function differences in children with type 1 diabetes: a functional MRI study of working memory.

Association of diabetes mellitus and structural changes in the central nervous system in children and adolescents: a systematic review. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes.

A systematic review and meta-analysis of executive function performance in type 1 diabetes mellitus. Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience.

A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes.

Effectiveness of a predictive algorithm in the prevention of exercise-induced hypoglycemia in type 1 diabetes. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.

Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes.

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes FLAIR : a multicentre, randomised, crossover trial.

A randomized trial of closed-loop control in children with type 1 diabetes. The evolution of hemoglobin A 1c targets for youth with type 1 diabetes: rationale and supporting evidence.

Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases. Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period association with hemoglobin A 1c and treatment modality.

Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control.

Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37, patients between and Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study.

Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes. Occurrence of severe hypoglycaemic events among US youth and young adults with type 1 or type 2 diabetes.

Incidence trends and predictors of hospitalization for hypoglycemia in 17, adult patients with type 1 diabetes: a Danish register linkage cohort study.

Target setting in intensive insulin management is associated with metabolic control: the Hvidoere Childhood Diabetes Study Group Centre Differences Study Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial.

In: ClinicalTrials. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A 1c levels in T1D exchange clinic registry participants.

Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range.

The relationship of hemoglobin A1C to time-in-range in patients with diabetes. Translating glycated hemoglobin A1c into time spent in glucose target range: a multicenter study. Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.

Autoimmune diseases in children and adults with type 1 diabetes from the T1D Exchange clinic registry. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus.

Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with type 1 diabetes.

Hyperthyroidism in children and adolescents with type 1 diabetes from Germany and Austria. Thyroid and islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with type 1 diabetes mellitus.

National Paediatric Diabetes Audit NPDA and the Royal College of Paediatrics and Child Health. Prevalence of celiac disease in 52, youth with type 1 diabetes: international comparison across three continents. Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology.

Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: analysis of the Type 1 Diabetes Exchange clinic registry.

Bone health in children with celiac disease assessed by dual x-ray absorptiometry: effect of gluten-free diet and predictive value of serum biochemical indices. Microvascular complications in childhood-onset type 1 diabetes and celiac disease: a multicenter longitudinal analysis of 56, patients from the German-Austrian DPV database.

A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease. Evidence supporting serology-based pathway for diagnosing celiac disease in asymptomatic children from high-risk groups. Clinical and metabolic effects of gluten free diet in children with type 1 diabetes and coeliac disease.

European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.

Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

Prevalence of cardiovascular disease risk factors in U. children and adolescents with diabetes: the SEARCH for Diabetes in Youth study. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Spectrum and prevalence of atherogenic risk factors in 27, children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system DPV.

Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes. Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex: the SEARCH for Diabetes in Youth Study.

Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study.

Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes. American Heart Association Council on Nutrition, Physical Activity and Metabolism. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.

Lipid profile and nutritional intake in children and adolescents with type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet. Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus?

There are unique challenges Low-calorie weight loss plans caring for children and adolescents Childrem T1DM that manxgement pediatric Energy metabolism and gut health Thermogenic exercise benefits care. These include the obvious differences in the size of the Choldren, developmental Children and diabetes management such as the unpredictability of a toddler's dietary intake Chilrren activity level and mqnagement to Offseason Conditioning Workouts symptoms diabetrs hypoglycemia, and medical issues such as the increased risk of hypoglycemia and diabetic ketoacidosis DKA. Because of these considerations, the management of a child with T1DM must take into account the age and developmental maturity of the child. Most children with T1DM present relatively early with the classic signs and symptoms of hyperglycemia and deficient insulin release, including polyuria and polydipsia, sometimes associated with polyphagia and weight loss. Approximately 30 percent of children present with severe insulin deficiency and DKA [ 1,2 ]. The topic below provides an overview of the management of T1DM in children who are not in DKA. High blood Essential fatty acid supplements from Offseason Conditioning Workouts properly treating the diabetes can damage the heart, blood vessels, kidneys, managemenh and nervous dibetes over many years. The two most common manafement of maagement are called Energy metabolism and gut health 1 and Offseason Conditioning Workouts 2 diabetes. Chidren forms can occur at any age, but children are more likely to be diagnosed with type 1 diabetes. Type 1 diabetes occurs when the pancreas does not produce enough of a hormone called insulin. This stops the body from being able to use sugar, which then build up in the bloodstream. These sugars also called glucose that cannot be used by the body pass out of the body in the urine and take water with it.